Cargando…

Genotypic resistance testing of HCV – is there a clinical need?

Persistent infections with the hepatitis C virus (HCV) pose a profound global public health burden. In the past 5 years treatment of chronic hepatitis C has dramatically changed. Novel direct-acting antivirals (DAAs) specifically inhibiting viral enzymes or factors that are essential for the viral r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Walker, Andreas, Kaiser, Rolf, Bartenschlager, Ralf, Timm, Jörg
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	German Medical Science GMS Publishing House 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6301723/ https://www.ncbi.nlm.nih.gov/pubmed/30671319 http://dx.doi.org/10.3205/id000023

Ejemplares similares

Detection of a genetic footprint of the sofosbuvir resistance-associated substitution S282T after HCV treatment failure
por: Walker, Andreas, et al.
Publicado: (2017)

Geno2pheno([HCV]) – A Web-based Interpretation System to Support Hepatitis C Treatment Decisions in the Era of Direct-Acting Antiviral Agents
por: Kalaghatgi, Prabhav, et al.
Publicado: (2016)

Performance of 6 HCV genotyping 9G test for HCV genotyping in clinical samples
por: Warkad, Shrikant Dasharath, et al.
Publicado: (2018)

A Novel Inhibitor IDPP Interferes with Entry and Egress of HCV by Targeting Glycoprotein E1 in a Genotype-Specific Manner
por: Lee, Myungeun, et al.
Publicado: (2017)

Transplantation of Renal Allografts From Organ Donors Reactive for HCV Antibodies to HCV-Negative Recipients: Safety and Clinical Outcome
por: Nowak, Knut Michael, et al.
Publicado: (2016)

The correlation of HCV RNA and HCV core antigen in different genotypes of HCV
por: Xiang, Yu, et al.
Publicado: (2018)

Pangenotypic and Genotype-Specific Antivirals in the Treatment of HCV Genotype 4 Infected Patients with HCV Monoinfection and HIV/HCV Coinfection
por: Zarębska-Michaluk, Dorota, et al.
Publicado: (2022)

HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes
por: Garbuglia, Anna Rosa, et al.
Publicado: (2014)

Compartmentalization of Resistance-Associated Substitutions in HIV/HCV-Infected Patients: Possible Correlation with Infecting HCV Genotype
por: Morsica, Giulia, et al.
Publicado: (2021)

Identification of Terfenadine as an Inhibitor of HumanCD81-Receptor HCV-E2 Interaction: Synthesis and Structure Optimization
por: Holzer, Marcel, et al.
Publicado: (2008)

Characterization of a multipurpose NS3 surface patch coordinating HCV replicase assembly and virion morphogenesis
por: Isken, Olaf, et al.
Publicado: (2022)

Epidemiological features of patients infected with HCV genotype 4 in Poland: Epidemiology of HCV genotype 4 in Poland
por: Chlabicz, Slawomir, et al.
Publicado: (2011)

Virologic Tools for HCV Drug Resistance Testing
por: Fourati, Slim, et al.
Publicado: (2015)

Are HIV, HBV and HCV Voluntary Counseling and Testing Programs Needed in Balkans?
por: Sultana, Camelia, et al.
Publicado: (2018)

HCV genotypes distribution pattern in India
por: Bokharaei-Salim, Farah, et al.
Publicado: (2012)

Prevalence of HCV genotypes in district Mardan
por: Afridi, Suliman Qadir, et al.
Publicado: (2013)

HCV Detection, Discrimination, and Genotyping Technologies
por: Warkad, Shrikant Dashrath, et al.
Publicado: (2018)

HCV Genotypes Are Differently Prone to the Development of Resistance to Linear and Macrocyclic Protease Inhibitors
por: Cento, Valeria, et al.
Publicado: (2012)

HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b
por: Pellicelli, Adriano M, et al.
Publicado: (2012)

Pre-Existing HCV Variants Resistant to DAAs and Their Sensitivity to PegIFN/RBV in Chinese HCV Genotype 1b Patients
por: Zhang, Yu, et al.
Publicado: (2016)

HCV Genotyping from NGS Short Reads and Its Application in Genotype Detection from HCV Mixed Infected Plasma
por: Qiu, Ping, et al.
Publicado: (2015)

Contribution of autophagy machinery factors to HCV and SARS-CoV-2 replication organelle formation
por: Twu, Woan-Ing, et al.
Publicado: (2021)

Genotypic tropism testing by massively parallel sequencing: qualitative and quantitative analysis
por: Däumer, Martin, et al.
Publicado: (2011)

Characterization of Samples Identified as Hepatitis C Virus Genotype 1 without Subtype by Abbott RealTime HCV Genotype II Assay Using the New Abbott HCV Genotype Plus RUO Test
por: Mokhtari, Camelia, et al.
Publicado: (2016)

Hepatitis C Virus (HCV) Genotype 1 Subtype Identification in New HCV Drug Development and Future Clinical Practice
por: Chevaliez, Stéphane, et al.
Publicado: (2009)

Investigation of NS3 Protease Resistance-Associated Variants and Phenotypes for the Prediction of Treatment Response to HCV Triple Therapy
por: Dietz, Julia, et al.
Publicado: (2016)

Determination of HCV genotypes and viral loads in chronic HCV infected patients of Hazara Pakistan
por: Ali, Amjad, et al.
Publicado: (2011)

HCV resistance
por: Halfon, Philippe
Publicado: (2012)

HCV genotyping using statistical classification approach
por: Qiu, Ping, et al.
Publicado: (2009)

HBV and HCV genotypes distribution on the territory of Belarus
por: Gasich, EL, et al.
Publicado: (2012)

Symmetric Anti-HCV Agents: Synthesis, Antiviral Properties, and Conformational Aspects of Core Scaffolds
por: Leila, Alaa R. S., et al.
Publicado: (2019)

A Healthcare-Associated Outbreak of HCV Genotype 2a at a Clinic in Seoul
por: Choi, Siwon, et al.
Publicado: (2021)

Prevalence of hepatitis C virus (HCV) variants resistant to NS5A inhibitors in naïve patients infected with HCV genotype 1 in Tunisia
por: Aissa Larousse, Jameleddine, et al.
Publicado: (2015)

Probe Capture Enrichment Methods for HIV and HCV Genome Sequencing and Drug Resistance Genotyping
por: Munyuza, Chantal, et al.
Publicado: (2022)

Comparison of HCV viral load and its genotype distributions in HCV mono- and HIV/HCV co-infected illicit drug users
por: Jamalidoust, Marzieh, et al.
Publicado: (2017)

Genotyping Pattern among Iranian HCV Positive Patients
por: Hajia, M, et al.
Publicado: (2010)

Distribution of HCV genotypes in Belgium from 2008 to 2015
por: Bouacida, Lobna, et al.
Publicado: (2018)

NS4A protein as a marker of HCV history suggests that different HCV genotypes originally evolved from genotype 1b
por: Sarwar, Muhammad T, et al.
Publicado: (2011)

Genotyping of HCV RNA Reveals That 3a Is the Most Prevalent Genotype in Mardan, Pakistan
por: Ali, Sajid, et al.
Publicado: (2014)

Variation analysis of six HCV viral load assays using low viremic HCV samples in the range of the clinical decision points for HCV protease inhibitors
por: Wiesmann, F., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_cssucmo07m091kbie2eaajgqv1